Gulf Investment Corp:企業の戦略的SWOT分析

◆英語タイトル:Gulf Investment Corp - Strategic SWOT Analysis Review
◆商品コード:GDFS104856SA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:クウェート
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Gulf Investment Corp – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Gulf Investment Corp (GIC) is a provider of asset management, corporate finance and advisory, consultancy, and fund administration services to public and private financial institutions. It is wholly-owned by Gulf Cooperation Council (GCC). The company invests in power, water, telecommunications, and other infrastructure; chemicals and metals; diversified industrials; materials; healthcare; agriculture; financial services; petrochemicals; steel; and electricity industries; among others. GIC also invests in corporate finance projects. GIC is headquartered at Kuwait City, Kuwait.

Gulf Investment Corp Key Recent Developments

Oct 04,2020: APICORP provides USD70.5 mn in financing to development of Phase 5 of the Mohammed bin Rashid Al Maktoum Solar Park
Sep 08,2020: ACWA Power signs $650m financing agreement for Jubail desalination water plant
Sep 04,2020: ACWA Power signs financing agreements for solar project in Dubai
Jul 02,2020: 500 MW IBRI 2 Solar PV project achieves a new milestone
May 03,2020: ACWA Power consortium including GIC and Al Bawani to enhance water security in Saudi Arabia with Jubail 3A IWP

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
Section 1 – About the Company
Gulf Investment Corp – Key Facts
Gulf Investment Corp – Key Employees
Gulf Investment Corp – Key Employee Biographies
Gulf Investment Corp – Major Products and Services
Gulf Investment Corp – History
Gulf Investment Corp – Company Statement
Gulf Investment Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Gulf Investment Corp – Business Description
Business Segment: Corporate and Other
Overview
Performance
Key Stats
Business Segment: Debt Capital Markets
Overview
Performance
Key Stats
Business Segment: Equity and Alternative Investments
Overview
Performance
Key Stats
Business Segment: Principal Investments
Overview
Performance
Key Stats
Business Segment: Treasury
Overview
Performance
Key Stats
Gulf Investment Corp – SWOT Analysis
SWOT Analysis – Overview
Gulf Investment Corp – Strengths
Gulf Investment Corp – Weaknesses
Gulf Investment Corp – Opportunities
Gulf Investment Corp – Threats
Gulf Investment Corp – Key Competitors
Gulf Investment Corp, Recent Deals Summary
Section 3 – Company’s Recent Developments
Oct 04, 2020: APICORP provides USD70.5 mn in financing to development of Phase 5 of the Mohammed bin Rashid Al Maktoum Solar Park
Sep 08, 2020: ACWA Power signs $650m financing agreement for Jubail desalination water plant
Sep 04, 2020: ACWA Power signs financing agreements for solar project in Dubai
Jul 02, 2020: 500 MW IBRI 2 Solar PV project achieves a new milestone
May 03, 2020: ACWA Power consortium including GIC and Al Bawani to enhance water security in Saudi Arabia with Jubail 3A IWP
Apr 30, 2020: Dubai achieves world record lowest ever pv tariff for 900 mw solar project
Mar 25, 2020: ACWA Power consortium secures financing for 500MW Ibri-2 solar project in Oman
Mar 24, 2020: Saudi energy consortium achieve financial closure for 500MW PV IPP
Jan 27, 2020: Bahrain LNG Import Terminal Achieves Construction Completion
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Gulf Investment Corp, Key Facts
Gulf Investment Corp, Key Employees
Gulf Investment Corp, Key Employee Biographies
Gulf Investment Corp, Major Products and Services
Gulf Investment Corp, History
Gulf Investment Corp, Subsidiaries
Gulf Investment Corp, Joint Venture
Gulf Investment Corp, Key Competitors
Gulf Investment Corp, Recent Deals Summary

★海外企業調査レポート[Gulf Investment Corp:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Allena Pharmaceuticals Inc (ALNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Allena Pharmaceuticals Inc (Allena) is a developer of oral enzyme therapeutics to treat patients with rare and severe metabolic disorders. The company develops ALLN-177, an oral recombinant oxalate degrading enzyme. It provides ALLN-177 which is developed for the chronic management of hypero …
  • Granules India Ltd (GRANULES):企業の財務・戦略的SWOT分析
    Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • University of Texas Health Science Center at San Antonio-製薬・医療分野:企業M&A・提携分析
    Summary University of Texas Health Science Center at San Antonio (UTHSCSA), a subsidiary of University of Texas System is an educational university that offers undergraduate, graduate, and research programs to physicians, biomedical scientists, aging and longevity, cancer, cardiovascular, diabetes, …
  • Heron Therapeutics Inc (HRTX)-製薬・医療分野:企業M&A・提携分析
    Summary Heron Therapeutics Inc (Heron), formerly A.P. Pharma, Inc., is a biotechnology company that uses its proprietary polymer-based drug delivery platform to develop novel, patient-focused therapeutic products for patients suffering from cancer and pain. Its proprietary Biochronomer technology is …
  • NABsys Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NABsys Inc (NABsys) is a biomedical service provider. The company designs and develops semiconductor-based tools for genomic analysis. It develops semiconductor based nanodetectors to analyze DNA molecules electronically. NABsys provides platform to detect the positions of hybridized DNA pro …
  • Catalyst Biosciences Inc (CBIO):医療機器:M&Aディール及び事業提携情報
    Summary Catalyst Biosciences Inc (Catalyst Biosciences), formerly Targacept Inc, is a clinical-stage biopharmaceutical company that develops protease-based advanced medicines to treat hematological indications. The company specializes in hemostasis, with focus on subcutaneous prophylaxis of hemophil …
  • Franz Haniel & Cie. GmbH:企業の戦略・SWOT・財務情報
    Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report Summary Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Mr. Price Group Ltd.
    Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Pfizer Inc (PFE):医療機器:M&Aディール及び事業提携情報
    Summary Pfizer Inc (Pfizer) is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, …
  • Mindax Limited:企業の戦略・SWOT・財務情報
    Mindax Limited - Strategy, SWOT and Corporate Finance Report Summary Mindax Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Kuraray Co., Ltd.:企業の戦略・SWOT・財務分析
    Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Encompass Home Health and Hospice-製薬・医療分野:企業M&A・提携分析
    Summary Encompass Home Health and Hospice (Encompass), formerly CareSouth Health System Inc, is a healthcare service provider that offers nursing care services. The center provides services including home healthcare, private duty home care, hospice, and health and wellness services. It offers manage …
  • JSC Insurance Company Aldagi:企業の戦略・SWOT・財務情報
    JSC Insurance Company Aldagi - Strategy, SWOT and Corporate Finance Report Summary JSC Insurance Company Aldagi - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Betta Pharmaceuticals Co Ltd (300558):製薬・医療:M&Aディール及び事業提携情報
    Summary Betta Pharmaceuticals Co Ltd (Betta Pharma) is a pharmaceutical company that researches, develops, manufactures and markets drugs for the treatment of cancer, cardiovascular diseases and diabetes. The company offers icotinib hydrochloride, an orally administered small-molecule, reversible ty …
  • Abeona Therapeutics Inc (ABEO):医療機器:M&Aディール及び事業提携情報
    Summary Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company that develops and delivers gene therapy and plasma-based products for severe and life-threatening rare diseases. The company’s lead programs include ABO-101 and ABO-102 adeno-associ …
  • UMN Pharma Inc (4585):企業の財務・戦略的SWOT分析
    Summary UMN Pharma Inc (UMN Pharma), a subsidiary of Shionogi Inc, is a biopharmaceutical company that manufactures therapeutic for muscular dystrophy, diabetes and influenza. The company’s pipeline products include UMN-101 for the treatment of Recombinant seasonal influenza vaccine; UMN-102 for rec …
  • vTv Therapeutics Inc (VTVT)-製薬・医療分野:企業M&A・提携分析
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc is a clinical stage pharmaceutical company that discovers, develops and commercializes small molecule drug candidates. The company’s pipeline products include azeliragon, TTP399, TTP273, HPP593, HPP737, HPP971 and hexokinase II inhibitors. I …
  • Aon plc:企業のM&A・事業提携・投資動向
    Aon plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aon plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Westlake Chemical Corp (WLK):企業の財務・戦略的SWOT分析
    Summary Westlake Chemical Corp (Westlake Chemical) is a manufacturer and supplier of petrochemicals, polymers and building products. The company offers products such as olefins, vinyls, styrene, polyethylene and epolene polymers. Westlake Chemical manufactures petrochemicals through olefins business …
  • Nuverra Environmental Solutions Inc (NES):企業の財務・戦略的SWOT分析
    Nuverra Environmental Solutions Inc (NES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆